Andreas Harstrick
Chief Executive Officer chez AFFIMED N.V.
Fortune : 213 765 $ au 31/03/2024
Profil
Andreas Harstrick is currently the Chief Executive & Medical Officer at Affimed NV.
He previously worked as a Director at Lilly Oncology, Senior Vice President-Medical Sciences at ImClone LLC from 2012 to 2014, Chief Medical Officer at Molecular Partners AG from 2015 to 2019, and SVP-Global Clinical Development Unit Oncology at Merck Serono Ltd.
from 1998 to 2008.
Dr. Harstrick obtained a doctorate degree from the University of Hannover in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AFFIMED N.V.
0,27% | 15/03/2023 | 40 333 ( 0,27% ) | 213 765 $ | 31/03/2024 |
Postes actifs de Andreas Harstrick
| Sociétés | Poste | Début |
|---|---|---|
| AFFIMED N.V. | Chief Executive Officer | 15/01/2024 |
Anciens postes connus de Andreas Harstrick
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR PARTNERS AG | Chief Tech/Sci/R&D Officer | 01/09/2019 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2014 |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | 01/01/2008 |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Director/Board Member | - |
Formation de Andreas Harstrick
| University of Hannover | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AFFIMED N.V. | Health Technology |
| MOLECULAR PARTNERS AG | Health Technology |
| Entreprise privées | 3 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Health Services |
